ASCORBIC ACID IN CHOLESTEROL AND BILE ACID METABOLISM

Latent chronic ascorbic acid deficiency provokes in guinea pigs a metabolic disorder in the liver, causing an impaired cholesterol transformation to its principal catabolic product, bile acids. This metabolic disorder induces hypercholesterolemia and accumulation of cholesterol in the liver and slow...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the New York Academy of Sciences 1975-09, Vol.258 (1), p.410-421
1. Verfasser: Ginter, Emil
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 421
container_issue 1
container_start_page 410
container_title Annals of the New York Academy of Sciences
container_volume 258
creator Ginter, Emil
description Latent chronic ascorbic acid deficiency provokes in guinea pigs a metabolic disorder in the liver, causing an impaired cholesterol transformation to its principal catabolic product, bile acids. This metabolic disorder induces hypercholesterolemia and accumulation of cholesterol in the liver and slows the release of cholesterol from the circulation. Ascorbic acid probably intervenes into the biosynthesis of bile acids at the stage of 7 alpha-hydroxylation of the cholesterol nucleus. High doses of ascorbic acid significantly stimulate cholesterol transformation to bile acids in guinea pigs and decrease plasma cholesterol concentration in humans.
doi_str_mv 10.1111/j.1749-6632.1975.tb29299.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_83170622</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>83170622</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4740-9be0d23b8d79bb7dcdbd87fb1d3d26b7db61ffcab8ca7dd1822f9b48b357e6733</originalsourceid><addsrcrecordid>eNqVkE9PgzAYhxujmXP6EUyIB29g_wClXgwwtmEYJGPGeGooLcnm5ibd4vbtBVmMV3tp0t_7e970AeAOQQs152FpIWoz03UJthCjjrUTmGHGrMMZ6P9G56APIaWmxzC5BFdaLyFE2LNpD_QQdKGNYB84fh5msyAODT-Mh0acGuEkS6J8Hs2yxPDToRHESdSF02juB1kS59NrcFEVK61uTvcAvIyieTgxk2wch35ilja1ocmEghIT4UnKhKCylEJ6tBJIEond5kG4qKrKQnhlQaVEHsYVE7YniEOVSwkZgPuOu603n3uld3y90KVarYoPtdlr7hFEoYtxM_jYDZb1RutaVXxbL9ZFfeQI8tYZX_JWDG_F8NYZPznjh6Z8e9qyF2sl_1R_JDX5U5d_LVbq-A8yT9_8vCOYHWGhd-rwSyjqd958s6m8pmPukBHOg-CZu-QbqTiGEA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>83170622</pqid></control><display><type>article</type><title>ASCORBIC ACID IN CHOLESTEROL AND BILE ACID METABOLISM</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Ginter, Emil</creator><creatorcontrib>Ginter, Emil</creatorcontrib><description>Latent chronic ascorbic acid deficiency provokes in guinea pigs a metabolic disorder in the liver, causing an impaired cholesterol transformation to its principal catabolic product, bile acids. This metabolic disorder induces hypercholesterolemia and accumulation of cholesterol in the liver and slows the release of cholesterol from the circulation. Ascorbic acid probably intervenes into the biosynthesis of bile acids at the stage of 7 alpha-hydroxylation of the cholesterol nucleus. High doses of ascorbic acid significantly stimulate cholesterol transformation to bile acids in guinea pigs and decrease plasma cholesterol concentration in humans.</description><identifier>ISSN: 0077-8923</identifier><identifier>EISSN: 1749-6632</identifier><identifier>DOI: 10.1111/j.1749-6632.1975.tb29299.x</identifier><identifier>PMID: 1060410</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Aged ; Animals ; Ascorbic Acid - administration &amp; dosage ; Ascorbic Acid - pharmacology ; Ascorbic Acid Deficiency - complications ; Ascorbic Acid Deficiency - metabolism ; Bile Acids and Salts - metabolism ; Cholesterol - metabolism ; Cholesterol - pharmacology ; Cholesterol, Dietary ; Female ; Guinea Pigs ; Humans ; Hypercholesterolemia - etiology ; Kinetics ; Liver - drug effects ; Liver - metabolism ; Male ; Middle Aged ; Spleen - drug effects ; Spleen - metabolism</subject><ispartof>Annals of the New York Academy of Sciences, 1975-09, Vol.258 (1), p.410-421</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4740-9be0d23b8d79bb7dcdbd87fb1d3d26b7db61ffcab8ca7dd1822f9b48b357e6733</citedby><cites>FETCH-LOGICAL-c4740-9be0d23b8d79bb7dcdbd87fb1d3d26b7db61ffcab8ca7dd1822f9b48b357e6733</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1749-6632.1975.tb29299.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1749-6632.1975.tb29299.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1060410$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ginter, Emil</creatorcontrib><title>ASCORBIC ACID IN CHOLESTEROL AND BILE ACID METABOLISM</title><title>Annals of the New York Academy of Sciences</title><addtitle>Ann N Y Acad Sci</addtitle><description>Latent chronic ascorbic acid deficiency provokes in guinea pigs a metabolic disorder in the liver, causing an impaired cholesterol transformation to its principal catabolic product, bile acids. This metabolic disorder induces hypercholesterolemia and accumulation of cholesterol in the liver and slows the release of cholesterol from the circulation. Ascorbic acid probably intervenes into the biosynthesis of bile acids at the stage of 7 alpha-hydroxylation of the cholesterol nucleus. High doses of ascorbic acid significantly stimulate cholesterol transformation to bile acids in guinea pigs and decrease plasma cholesterol concentration in humans.</description><subject>Aged</subject><subject>Animals</subject><subject>Ascorbic Acid - administration &amp; dosage</subject><subject>Ascorbic Acid - pharmacology</subject><subject>Ascorbic Acid Deficiency - complications</subject><subject>Ascorbic Acid Deficiency - metabolism</subject><subject>Bile Acids and Salts - metabolism</subject><subject>Cholesterol - metabolism</subject><subject>Cholesterol - pharmacology</subject><subject>Cholesterol, Dietary</subject><subject>Female</subject><subject>Guinea Pigs</subject><subject>Humans</subject><subject>Hypercholesterolemia - etiology</subject><subject>Kinetics</subject><subject>Liver - drug effects</subject><subject>Liver - metabolism</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Spleen - drug effects</subject><subject>Spleen - metabolism</subject><issn>0077-8923</issn><issn>1749-6632</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1975</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkE9PgzAYhxujmXP6EUyIB29g_wClXgwwtmEYJGPGeGooLcnm5ibd4vbtBVmMV3tp0t_7e970AeAOQQs152FpIWoz03UJthCjjrUTmGHGrMMZ6P9G56APIaWmxzC5BFdaLyFE2LNpD_QQdKGNYB84fh5msyAODT-Mh0acGuEkS6J8Hs2yxPDToRHESdSF02juB1kS59NrcFEVK61uTvcAvIyieTgxk2wch35ilja1ocmEghIT4UnKhKCylEJ6tBJIEond5kG4qKrKQnhlQaVEHsYVE7YniEOVSwkZgPuOu603n3uld3y90KVarYoPtdlr7hFEoYtxM_jYDZb1RutaVXxbL9ZFfeQI8tYZX_JWDG_F8NYZPznjh6Z8e9qyF2sl_1R_JDX5U5d_LVbq-A8yT9_8vCOYHWGhd-rwSyjqd958s6m8pmPukBHOg-CZu-QbqTiGEA</recordid><startdate>197509</startdate><enddate>197509</enddate><creator>Ginter, Emil</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>197509</creationdate><title>ASCORBIC ACID IN CHOLESTEROL AND BILE ACID METABOLISM</title><author>Ginter, Emil</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4740-9be0d23b8d79bb7dcdbd87fb1d3d26b7db61ffcab8ca7dd1822f9b48b357e6733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1975</creationdate><topic>Aged</topic><topic>Animals</topic><topic>Ascorbic Acid - administration &amp; dosage</topic><topic>Ascorbic Acid - pharmacology</topic><topic>Ascorbic Acid Deficiency - complications</topic><topic>Ascorbic Acid Deficiency - metabolism</topic><topic>Bile Acids and Salts - metabolism</topic><topic>Cholesterol - metabolism</topic><topic>Cholesterol - pharmacology</topic><topic>Cholesterol, Dietary</topic><topic>Female</topic><topic>Guinea Pigs</topic><topic>Humans</topic><topic>Hypercholesterolemia - etiology</topic><topic>Kinetics</topic><topic>Liver - drug effects</topic><topic>Liver - metabolism</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Spleen - drug effects</topic><topic>Spleen - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ginter, Emil</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of the New York Academy of Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ginter, Emil</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ASCORBIC ACID IN CHOLESTEROL AND BILE ACID METABOLISM</atitle><jtitle>Annals of the New York Academy of Sciences</jtitle><addtitle>Ann N Y Acad Sci</addtitle><date>1975-09</date><risdate>1975</risdate><volume>258</volume><issue>1</issue><spage>410</spage><epage>421</epage><pages>410-421</pages><issn>0077-8923</issn><eissn>1749-6632</eissn><abstract>Latent chronic ascorbic acid deficiency provokes in guinea pigs a metabolic disorder in the liver, causing an impaired cholesterol transformation to its principal catabolic product, bile acids. This metabolic disorder induces hypercholesterolemia and accumulation of cholesterol in the liver and slows the release of cholesterol from the circulation. Ascorbic acid probably intervenes into the biosynthesis of bile acids at the stage of 7 alpha-hydroxylation of the cholesterol nucleus. High doses of ascorbic acid significantly stimulate cholesterol transformation to bile acids in guinea pigs and decrease plasma cholesterol concentration in humans.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>1060410</pmid><doi>10.1111/j.1749-6632.1975.tb29299.x</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0077-8923
ispartof Annals of the New York Academy of Sciences, 1975-09, Vol.258 (1), p.410-421
issn 0077-8923
1749-6632
language eng
recordid cdi_proquest_miscellaneous_83170622
source MEDLINE; Access via Wiley Online Library
subjects Aged
Animals
Ascorbic Acid - administration & dosage
Ascorbic Acid - pharmacology
Ascorbic Acid Deficiency - complications
Ascorbic Acid Deficiency - metabolism
Bile Acids and Salts - metabolism
Cholesterol - metabolism
Cholesterol - pharmacology
Cholesterol, Dietary
Female
Guinea Pigs
Humans
Hypercholesterolemia - etiology
Kinetics
Liver - drug effects
Liver - metabolism
Male
Middle Aged
Spleen - drug effects
Spleen - metabolism
title ASCORBIC ACID IN CHOLESTEROL AND BILE ACID METABOLISM
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T13%3A30%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ASCORBIC%20ACID%20IN%20CHOLESTEROL%20AND%20BILE%20ACID%20METABOLISM&rft.jtitle=Annals%20of%20the%20New%20York%20Academy%20of%20Sciences&rft.au=Ginter,%20Emil&rft.date=1975-09&rft.volume=258&rft.issue=1&rft.spage=410&rft.epage=421&rft.pages=410-421&rft.issn=0077-8923&rft.eissn=1749-6632&rft_id=info:doi/10.1111/j.1749-6632.1975.tb29299.x&rft_dat=%3Cproquest_cross%3E83170622%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=83170622&rft_id=info:pmid/1060410&rfr_iscdi=true